Division of Hematology/Oncology,
Department of Medicine,
Division of Hematology/Oncology, Department of Medicine
Alison Loren has not added Biography.
If you are Alison Loren and would like to personalize this page please email our Author Liaison for assistance.
Re: Life after radical prostatectomy: a longitudinal study.
The Journal of urology Jul, 2002 | Pubmed ID: 12050540
Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma.
Transplantation Aug, 2003 | Pubmed ID: 12973122
Derivation of malignancy status from ICD-9 codes.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium , 2003 | Pubmed ID: 14728553
Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura.
American journal of hematology Jul, 2004 | Pubmed ID: 15224362
Post-transplant lymphoproliferative disorder.
Clinics in chest medicine Dec, 2005 | Pubmed ID: 16263402
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.
Blood Feb, 2006 | Pubmed ID: 16269610
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation.
Current opinion in oncology Mar, 2006 | Pubmed ID: 16462177
A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
Leukemia & lymphoma May, 2006 | Pubmed ID: 16753873
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jul, 2006 | Pubmed ID: 16785065
Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
Journal of the American Academy of Dermatology Mar, 2007 | Pubmed ID: 17187896
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
Cancer biology & therapy Jan, 2007 | Pubmed ID: 17204865
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
American journal of hematology Dec, 2007 | Pubmed ID: 17696204
Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
Medical oncology (Northwood, London, England) , 2008 | Pubmed ID: 18181037
Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.
American journal of hematology Jul, 2008 | Pubmed ID: 18335564
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2008 | Pubmed ID: 18765556
Severe eosinophilia as a manifestation of acute graft-versus-host disease.
Oncology , 2008 | Pubmed ID: 18791329
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
American journal of hematology Nov, 2008 | Pubmed ID: 18819096
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies.
Cancer biology & therapy Jun, 2009 | Pubmed ID: 19652524
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2009 | Pubmed ID: 19843663
Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Feb, 2011 | Pubmed ID: 20659574
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Dec, 2011 | Pubmed ID: 21771571
Congestive heart failure in a patient with cutaneous T-cell lymphoma treated with low-dose interferon alfa-2b.
Archives of dermatology Sep, 2011 | Pubmed ID: 21931064
HLA DR15 Antigen Status Does Not Impact Graft-versus-Host Disease or Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar, 2012 | Pubmed ID: 22414493
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.
The New England journal of medicine Jul, 2012 | Pubmed ID: 22784116
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Blood Jan, 2013 | Pubmed ID: 23109243
Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune disease.
Leukemia & lymphoma Jun, 2013 | Pubmed ID: 23216270
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jul, 2013 | Pubmed ID: 23635453
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
American journal of hematology Aug, 2013 | Pubmed ID: 23640768
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.
Blood Jun, 2013 | Pubmed ID: 23641016
Dasatinib-induced leukotrichia in a patient with chronic myelogenous leukemia.
JAMA dermatology May, 2013 | Pubmed ID: 23677113
IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus.
The Journal of investigative dermatology Dec, 2013 | Pubmed ID: 23698099
Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2013 | Pubmed ID: 23715580
Providing personalized prognostic information for adult leukemia survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Nov, 2013 | Pubmed ID: 24018394
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.
Blood Dec, 2013 | Pubmed ID: 24065243
CLL/SLL diagnosed in an adolescent.
Pediatric blood & cancer Jun, 2014 | Pubmed ID: 24281971
Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimen.
Clinical lymphoma, myeloma & leukemia Apr, 2014 | Pubmed ID: 24393621
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.
Cancer Aug, 2014 | Pubmed ID: 24771533
Contraceptive use and the role of contraceptive counseling in reproductive-aged women with cancer.
Contraception Jul, 2014 | Pubmed ID: 24792148
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Nov, 2014 | Pubmed ID: 25016197
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Nov, 2014 | Pubmed ID: 25042734
R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.
Clinical lymphoma, myeloma & leukemia Feb, 2015 | Pubmed ID: 25174772
Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jan, 2015 | Pubmed ID: 25316109
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Feb, 2015 | Pubmed ID: 25445023
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar, 2015 | Pubmed ID: 25528388
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Apr, 2015 | Pubmed ID: 25543093
DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2015 | Pubmed ID: 25609058
Implementation of an Advanced Practice Provider Service on an Allogeneic Stem Cell Transplant Unit: Impact on Patient Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Sep, 2015 | Pubmed ID: 26028503
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2015 | Pubmed ID: 26056179
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.
Clinical lymphoma, myeloma & leukemia Sep, 2015 | Pubmed ID: 26141214
A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.
Current hematologic malignancy reports Sep, 2015 | Pubmed ID: 26162948
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.
Science translational medicine Sep, 2015 | Pubmed ID: 26333935
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
British journal of haematology Jul, 2016 | Pubmed ID: 26403537
Fertility issues in patients with hematologic malignancies.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program , 2015 | Pubmed ID: 26637713
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
American journal of hematology Jun, 2016 | Pubmed ID: 26820493
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
American journal of hematology May, 2016 | Pubmed ID: 26858124
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
American journal of hematology Jul, 2016 | Pubmed ID: 27012928
Rising.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun, 2016 | Pubmed ID: 27091713
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
American journal of hematology Sep, 2016 | Pubmed ID: 27197602
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.
JCI insight Jun, 2016 | Pubmed ID: 27446991
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.
American journal of hematology Jul, 2016 | Pubmed ID: 27468137
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유